Literature DB >> 11964034

Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS).

D Macut1, D Micić, G Cvijović, M Sumarac, A Kendereski, S Zorić, D Pejković.   

Abstract

Women with polycystic ovary syndrome (PCOS) could have associated risk for cardiovascular disease. The aim of the present study was to investigate the relationship between age and metabolic factors on cardiovascular risk in obese women with PCOS. Obese patients with PCOS were divided into an adolescent group (n=11; age 16.90 +/- 0.45 yr; BMI 35.04 +/- 1.70 kg/m2), and an adult group (n=18; age 29.66 +/- 1.31; BMI 34.57 +/- 1.46). We determined basal values of glucose, insulin, lipid and fibrinolytic parameters from blood samples taken in all patients and matched controls. Significantly different concentrations between the groups with PCOS were obtained for glucose, total cholesterol, triglycerides, LDL-cholesterol and Apo-B. Elevated concentrations of insulin (20.63 mU/l), both insulin sensitivity indexes--G:I ratio (7.52 mg/10(-4) U) and HOMA model (4.11 mmol/l x U/l(2))--and PAI-1 (5.49 U/ml) were obtained in the adolescent group with PCOS compared to controls, with further increase in the adult group with PCOS. It seems that the youngest obese population with PCOS represents a cohort with potential cardiovascular disease in adulthood.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11964034

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

Review 1.  Cardiovascular risk factors and events in women with androgen excess.

Authors:  D Macut; I B Antić; J Bjekić-Macut
Journal:  J Endocrinol Invest       Date:  2014-11-29       Impact factor: 4.256

2.  Clinical features, investigations and management of adolescents with polycystic ovary syndrome.

Authors:  Angela Orsino; Nancy Van Eyk; Jill Hamilton
Journal:  Paediatr Child Health       Date:  2005-12       Impact factor: 2.253

3.  ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome.

Authors:  Donna F Vine; Lawrence J Beilin; Sally Burrows; Rae-Chi Huang; Martha Hickey; Roger Hart; Spencer D Proctor; Trevor A Mori
Journal:  J Endocr Soc       Date:  2020-05-26

4.  Age, Body Mass Index, and Waist-to-Hip Ratio Related Changes in Insulin Secretion  and  Insulin Sensitivity in Women  with Polycystic Ovary Syndrome: Minimal Model Analyses.

Authors:  Mirjana Šumarac-Dumanović; Danica Stamenković-Pejković; Danka Jeremić; Janko Dumanović; Vesna Mandić-Marković; Miloš Žarković; Dragan Micić
Journal:  Int J Endocrinol       Date:  2022-05-18       Impact factor: 2.803

5.  Fasting Glucose Changes in Adolescents with Polycystic Ovary Syndrome Compared with Obese Controls: A Retrospective Cohort Study.

Authors:  Asma Javed; Aida N Lteif; Seema Kumar; Patricia S Simmons; Alice Y Chang
Journal:  J Pediatr Adolesc Gynecol       Date:  2015-01-07       Impact factor: 1.814

6.  Metabolic effects of polycystic ovary syndrome in adolescents.

Authors:  Yejin Han; Hae Soon Kim; Hye-Jin Lee; Jee-Young Oh; Yeon-Ah Sung
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-09-30

7.  Evaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (the Doi Score) in Women with Polycystic Ovary Syndrome and its Relationship with Obesity.

Authors:  Iva Perović Blagojević; Svetlana Ignjatović; Djuro Macut; Jelena Kotur-Stevuljević; Ivana Božić-Antić; Jelena Vekić; Jelica Bjekić-Macut; Biljana Kastratović-Kotlica; Zoran Andrić; Dušan Ilić
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.